SCHEMBL8407256

SCHEMBL8407256

CC(O)(C(=O)Nc1cc(Cl)c(Cl)c(Cl)c1)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK1 Q15118 1/20 0.51
PDK2 Q15119 1/20 0.51
PDK3 Q15120 1/20 0.51
PDK4 Q16654 1/20 0.51
KMT2A Q03164 10/20 0.47
MEN1 O00255 8/20 0.47
MAPT P10636 7/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
HPGD P15428 2/20 0.47
HTT P42858 2/20 0.47
MAPK1 P28482 1/20 0.47
HTR1E P28566 1/20 0.43
S1PR3 Q99500 1/20 0.43
ALDH1A1 P00352 3/20 0.41
RAB9A P51151 3/20 0.41
LMNA P02545 2/20 0.41
NPC1 O15118 1/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8407302 0.89 MAPT (0.51) PDK1PDK2PDK3PDK4KMT2A
SCHEMBL8407500 0.86 MAPT (0.50) PDK1PDK2PDK3PDK4KMT2A
SCHEMBL8410731 0.83 HSD11B1 (0.46) PDK1PDK2PDK3PDK4KMT2A
SCHEMBL8409371 0.82 PDK1 (0.57) PDK1PDK2PDK3PDK4KMT2A
SCHEMBL8407128 0.76 AR (0.57) KMT2AMEN1MAPTMAPK1LMNA
SCHEMBL8408906 0.75 AR (0.72) SMN1; SMN2HTTMAPK1ALDH1A1LMNA
SCHEMBL17054778 0.72 POLB (0.52) KMT2AMEN1MAPTSMN1; SMN2HPGD
SCHEMBL11668848 0.72 GAA (0.46) PDK1PDK2PDK3PDK4HTT
SCHEMBL8410597 0.72 AR (0.64)
SCHEMBL10967242 0.72 KMT2A (0.47) PDK1PDK2PDK3PDK4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5994362-A ADMINISTERING FINASTERIDE AND CASODEX MERCK & CO., INC. (US) 1999-11-30 US disclosed
EP-0514056-A2 Use of estrogens or antiandrogens for reversal of male sexual phenotype in poultry MERCK & CO. INC. (US) 1992-11-19 EP disclosed
WO-1992016233-A1 PHARMACEUTICAL COMBINATION FOR THE TREATMENT OF PROSTATIC CANCER CONTAINING A 5 ALPHA REDUCTASE INHIBITOR AND AN ANTIANDROGEN MERCK & CO., INC. (US) 1992-10-01 WO disclosed
EP-0040932-B1 AMIDE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL OR VETERINARY COMPOSITIONS CONTAINING THEM IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-07-03 EP disclosed
US-4386080-A 3,4-DISUBSTITUTED-N-ACYLANILINES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1983-05-31 US disclosed